# Illumina, Inc.: Form 10-K for the period ended Dec 29, 2024

- Company: [Illumina, Inc.](/companies/ilmn.md) (CIK 1110803)
- Form: 10-K
- Filed: 2025-02-12
- Accepted by EDGAR: Feb 12, 2025, 16:21 ET
- Period: 2024-12-29
- Accession: 0001110803-25-000019
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1110803/000111080325000019/ilmn-20241229.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1110803/000111080325000019/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-12-29.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2024-01-01 to 2024-12-29 | $4.37bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months, 2024-01-01 to 2024-12-29 | $1.51bn | us-gaap:CostOfRevenue |
| Gross profit | 12 months, 2024-01-01 to 2024-12-29 | $2.86bn | us-gaap:GrossProfit |
| Research and development | 12 months, 2024-01-01 to 2024-12-29 | $1.17bn | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months, 2024-01-01 to 2024-12-29 | $1.09bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months, 2024-01-01 to 2024-12-29 | −$833.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2024-01-01 to 2024-12-29 | $100.0m | us-gaap:InterestExpenseNonoperating |
| Income tax | 12 months, 2024-01-01 to 2024-12-29 | $44.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2024-01-01 to 2024-12-29 | −$1.22bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2024-01-01 to 2024-12-29 | −$7.69 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2024-01-01 to 2024-12-29 | −$7.69 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2024-01-01 to 2024-12-29 | 159,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2024-01-01 to 2024-12-29 | $837.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2024-01-01 to 2024-12-29 | $128.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months, 2024-01-01 to 2024-12-29 | $116.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | at 2024-12-29 | $2.75bn | us-gaap:AssetsCurrent |
| Total assets | at 2024-12-29 | $6.30bn | us-gaap:Assets |
| Current liabilities | at 2024-12-29 | $1.55bn | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | at 2024-12-29 | $2.37bn | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1110803/000111080325000019/ilmn-20241229.htm

Filed Feb 12, 2025.
Source: SEC EDGAR, the filing index for accession 0001110803-25-000019. Last ingested by Listed: Nov 14, 2026, 13:59 ET. No prices; not investment advice.
